Sign In

Stephan Stenglein

Chief Medical Officer at Atriva Therapeutics GmbH

Dr. med. Stephan Stenglein, an accomplished drug developer, has a successful track record in late-stage development of biologics, small molecules, vaccines, and digital medical devices.

With a background in clinical virology, he possesses extensive experience in the global pharmaceutical industry across various geographies and cultures.

Stephan is renowned for his strong business acumen and leadership skills, particularly in change-oriented environments, focusing on Infectious Diseases, Respiratory, Hematology, and CNS indications.

His expertise spans drug development in Infectious Diseases, Clinical & Molecular Virology, Vaccines, Antivirals, Antibiotics, Respiratory late-stage development, and Medical Affairs.

Additionally, he is well-versed in Inhalation devices and Medical Devices ranging from Class I to III.

Stephan Stenglein pursued his Doctor of Medicine degree at the Univ. Erlangen-Nuernberg Medical School in Bavaria, Germany.

Throughout his career, he has held key roles including Chief Medical Officer at Atriva Therapeutics GmbH and various positions at renowned pharmaceutical companies like AstraZeneca, Novartis, Glenmark Pharmaceuticals, Shire, and Medtronic.

His professional journey includes leadership roles such as VP Head Late Stage Development Respiratory, Global Program Clinical Head (Respiratory), Global Program Medical Director (Respiratory Franchise), Sr. Clinical Research Physician Vaccines, VP Clinical Sciences, and Global Brand Medical Director.

Dr. Stenglein's expertise, experience, and leadership have made him a respected figure in the pharmaceutical industry, particularly in the areas of drug development and medical affairs.

Stephan Stenglein
Add to my network

Location

Frankfurt Rhine-Main Metropolitan Area